Michael Hsieh has spent his entire career focused on finance and accounting including over 7 years as a biotech startup CFO and 22 years in corporate finance investment banking. Most recently he was CFO for Meditope Biosciences, an early-stage biotech startup focused on developing the next generation of oncology therapeutics. Prior to that he was a director in the Leveraged Finance Group at BMO Capital Markets Corp., where he spent 8 years focused on the healthcare sector. He has direct experience in all forms of corporate finance including capital raising (both equity and debt) and mergers and acquisitions for all sizes of companies across a wide spectrum of industries. Mr. Hsieh holds a B.S. in Finance from the University of Illinois in Champaign-Urbana.